Medscape
Medscape Ob/Gyn & Women's Health PodcastEpisodes
Episodes of Medscape Ob/Gyn & Women's Health Podcast
Mark All
Search Episodes...
Dr JoAnn Manson highlights temporal trends in the use of antihypertensive medications in women with preeclampsia and the risk for maternal stroke.
There is no evidence that screening actually improves outcomes in ovarian cancer, according to a USPSTF analysis of the best available data.
Does a recent study support the use of vaginal estrogen in women with genitourinary syndrome of menopause?
Dr Peter Yellowlees talks about the association between hormonal contraception and suicide.
Dr JoAnn Manson describes findings of a recent study showing that walking farther and faster can prevent heart failure in women.
Dr Kathy Miller speaks with APHINITY's principal investigator about whether survival in HER2+ disease can be pushed even further.
Dr Andrew Kaunitz highlights an important study, with implications for vaginal examination and cervical cancer screening in obese women.
The risk for uterine sarcoma being found in fibroids is too high, notes Dr Markman.
Dr JoAnn Manson offers clinicians a new resource to guide discussions with patients about vitamins and supplements.
Drs Kathy Miller and Reshma Jagsi on the reasons behind practitioners' reluctance to omit radiation therapy in older patients.
A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman.
New research explores the risk/benefit profile of reproductive hormone therapy in menopausal women with migraine.
Some think it's time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017.
Dr George Lundberg urges discussion on modern sexual ethics.
The latest surveillance report reveals that sexually transmitted infections are again on the rise.
Dr Andrew Kaunitz comments on new studies that look at opioid prescribing in obstetrics and gynecology.
Hormone therapy must be discussed and individualized for each patient in order to achieve the best outcome for treating menopause.
Does this COX-2 inhibitor alter breast cancer risk? Dr Kathy Miller discusses the results of the REACT trial with its primary investigator, Dr Charles Coombes.
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy.
Dr Walton-Shirley reviews the key updates in the 2017 ACC/AHA guidelines for the Prevention, Detection, Evaluation and Management of High Blood Pressure with the guideline chair.
Drug holidays should not be taken when using denosumab; molecular breast imaging may outperform mammography; and other topics, as reviewed during the NAMS annual meeting.
Dr JoAnn Manson comments on a recent study revealing that gestational diabetes is like a window into a woman's future risk for cardiovascular disease and type 2 diabetes.
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society.
ACOG no longer recommends breast self-exams to average-risk women, but it does recommend breast education and awareness.
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says.
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us